{"id":3814,"date":"2022-10-07T13:24:53","date_gmt":"2022-10-07T18:24:53","guid":{"rendered":"https:\/\/lsom.uthscsa.edu\/dcsa\/?page_id=3814"},"modified":"2022-10-10T09:06:36","modified_gmt":"2022-10-10T14:06:36","slug":"mentors","status":"publish","type":"page","link":"https:\/\/lsom.uthscsa.edu\/dcsa\/education\/nci-t32\/mentors\/","title":{"rendered":"Mentors – NCI\/T32: Cancer Research Training Program"},"content":{"rendered":"

[vc_row][vc_column width=”2\/3″][vc_column_text]\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Name\/Degree(s)<\/th>Research Interest<\/th>\n<\/tr>\n<\/thead>\n
Aguiar, Ricardo C., MD, PhD<\/a><\/td>Molecular mechanisms of B-lymphomagenesis<\/td>\n<\/tr>\n
Boyer, Thomas G., PhD<\/a><\/td>Transcriptional regulation in oncogenesis<\/td>\n<\/tr>\n
Brenner, Andrew, MD, PhD<\/a><\/td>Gliomas and GBM; experimental therapeutics<\/td>\n<\/tr>\n
Burma, Sandeep, PhD<\/a><\/td>DNA Damage repair pathways, glioblastoma therapy resistance<\/td>\n<\/tr>\n
Chen, Yidong, PhD<\/a><\/td>Computational biology and cancer bioinformatics<\/td>\n<\/tr>\n
Dahia, Patricia L., MD, PhD<\/a><\/td>Genetics and genomics of cancers especially pheochromocytomas and paragangliomas<\/td>\n<\/tr>\n
Gius, David, MD, PhD<\/a><\/td>Aging, DNA damage, and carcinogenesis<\/td>\n<\/tr>\n
Griffith, Ann V., PhD<\/a><\/td>Lymphopoietic stromal microenvironment in the thymus<\/td>\n<\/tr>\n
Gupta, Yogesh, PhD<\/a><\/td>Combining structural biology and cell-based methods to elucidate the role of RNA modifications in cancers to develop novel therapies <\/td>\n<\/tr>\n
Harris, Rueben, PhD<\/a><\/td>Infectious Disease, Biochemistry, Bioinformatics, Cell Biology, genetic engineering, molecular biology, structural biology, and virology<\/td>\n<\/tr>\n
Houghton, Peter J., PhD<\/a><\/td>Pediatric cancers, sarcomas, experimental therapeutics<\/td>\n<\/tr>\n
Hromas, Robert A., MD, FACP<\/a><\/td>Hematology, cancer treatment<\/td>\n<\/tr>\n
Huang, Gang, PhD<\/a><\/td>Leukemia, lymphoma, renal cell carcinoma gastrointestinal stromal tumor glioma<\/td>\n<\/tr>\n
Huang, Tim H-M., PhD<\/a><\/td>Epigenetic mechanisms in cancer<\/td>\n<\/tr>\n
Jiang, Jean X., PhD<\/a><\/td>Cell-to-cell communication in cancer; connexins and hemi-channels <\/td>\n<\/tr>\n
Jin, Lingtao, PhD<\/a><\/td>Complex signaling control mechanism underlying anti-Cancer therapy resistance<\/td>\n<\/tr>\n
Kumar, A. Pratap, PhD<\/a><\/td>Nutritional intervention and prostate carcinogenesis<\/td>\n<\/tr>\n
Lee, Sang Eun, PhD<\/a><\/td>Molecular genetics of DNA damage response<\/td>\n<\/tr>\n
Libich David, PhD<\/a><\/td>Structural implications of EWS-FLI1 as the sole driver in Ewing\u2019s sarcoma <\/td>\n<\/tr>\n
Liu, (Jason) Zhijie, PhD<\/a><\/td>Regulation of signal-dependent gene programs in cell differentiation\/dedifferentiation in the development of cancer and other diseases<\/td>\n<\/tr>\n
Rao, Manjeet K., PhD<\/a><\/td>RNA interference, molecular carcinogenesis, epigenetic regulation in cancer; medulloblastoma<\/td>\n<\/tr>\n
Risinger, April, PhD<\/a><\/td>Preclinical development of novel natural products for cancer treatment<\/td>\n<\/tr>\n
Sareddy, Gangadhara, PhD<\/a><\/td>Hormonal signaling and epigenetic mechanisms in glioblastoma and gynecologic malignancies<\/td>\n<\/tr>\n
Shiio, Yuzuru, MD, PhD<\/a><\/td>Cytokine signaling and function of fusion oncoproteins in children\u2019s cancers; Ewing's sarcoma<\/td>\n<\/tr>\n
Sun, LuZhe, PhD<\/a><\/td>Liver cancer, cancer stem cells, experimental therapeutics<\/td>\n<\/tr>\n
Sun, Xiaoli, MD, PhD<\/a><\/td>Metabolic Diseases and Lipid Metabolism associated with hepatocellular carcinoma <\/td>\n<\/tr>\n
Sung, Patrick, PhD<\/a><\/td>DNA Damage repair pathways<\/td>\n<\/tr>\n
Vadlamudi, Ratna K., PhD<\/a><\/td>Signal transduction and steroid hormones in carcinogenesis<\/td>\n<\/tr>\n
Vaseva, Angelina, PhD<\/a><\/td>Design therapeutic strategies for RAS-driven pediatric cancers.<\/td>\n<\/tr>\n
Viswanadhapalli, Suryavathi, PhD<\/a><\/td>Women Cancer Progression, small molecules targeting novel oncogenes, and therapy resistance<\/td>\n<\/tr>\n
Wang, Pei, PhD<\/a><\/td>pancreas biology and tumorigenesis of pancreatic cancer<\/td>\n<\/tr>\n
Xu, Kexin, PhD<\/a><\/td>Epigenetic regulation, prostate cancer<\/td>\n<\/tr>\n
Xu, Mingiang MD, PhD<\/a><\/td>Identifying epigenetic-focused targets for the treatment of hematologic malignancies <\/td>\n<\/tr>\n
Xu, Zhenming, PhD<\/a><\/td>Differentiation and functions of B lymphocytes in antibody responses to infectious pathogens and vaccines, and cancer<\/td>\n<\/tr>\n
Yang, Feng-Chun, MD, PhD<\/a><\/td>Cellular and molecular mechanisms underlying myeloid malignancies<\/td>\n<\/tr>\n
Zhang, Nu, PhD<\/a><\/td>Differentiation and retention of tissue resident memory T cells and cancer<\/td>\n<\/tr>\n
Zhao, Peng, PhD<\/a><\/td>metabolic homeostasis and liver cancer <\/td>\n<\/tr>\n
Zhao, Weixing, PhD<\/a><\/td>BRCA1\/2 biology and the implication of BRCA 1 Mutation in Triple negative breast Cancer Development<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n[\/vc_column_text][\/vc_column][vc_column width=”1\/3″]